Nature's Sunshine Products Shares Outstanding 2006-2019 | NATR

Nature's Sunshine Products shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Nature's Sunshine Products Annual Shares Outstanding
(Millions of Shares)
2018 19
2017 19
2016 19
2015 19
2014 18
2013 16
2012 16
2011 16
2010 16
2009 16
2008 16
2007 15
2006 15
2005 16
Nature's Sunshine Products Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 20
Q2 2019 20
Q1 2019 20
Q4 2018 19
Q3 2018 19
Q2 2018 19
Q1 2018 19
Q4 2017 19
Q3 2017 19
Q2 2017 19
Q1 2017 19
Q4 2016 19
Q3 2016 19
Q2 2016 19
Q1 2016 19
Q4 2015 19
Q3 2015 19
Q2 2015 19
Q1 2015 19
Q4 2014 18
Q3 2014 18
Q2 2014 16
Q1 2014 17
Q4 2013 16
Q3 2013 16
Q2 2013 16
Q1 2013 16
Q4 2012 16
Q3 2012 16
Q2 2012 16
Q1 2012 16
Q4 2011 16
Q3 2011 16
Q2 2011 16
Q1 2011 16
Q4 2010 16
Q3 2010 16
Q2 2010 16
Q1 2010 16
Q4 2009 16
Q3 2009 16
Q2 2009 16
Q1 2009 16
Q4 2008 16
Q3 2008 16
Q2 2008 16
Q1 2008 16
Q4 2007 15
Q3 2007 16
Q2 2007 15
Q1 2007 15
Q4 2005 16
Q3 2005 16
Q2 2005 16
Q1 2005 15
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.186B $0.365B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.986B 39.47
Takeda Pharmaceutical (TAK) Japan $62.405B 9.86
Astellas Pharma (ALPMY) Japan $32.601B 16.28
Eisai (ESALY) Japan $21.377B 41.22
Merck (MKGAF) Germany $16.627B 22.69
Grifols, S.A (GRFS) Spain $16.212B 21.24
Neurocrine Biosciences (NBIX) United States $9.887B 466.78
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.901B 36.21
Ionis Pharmaceuticals (IONS) United States $8.730B 17.68
Jazz Pharmaceuticals (JAZZ) Ireland $8.641B 11.04
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
IPSEN SA ADR (IPSEY) France $7.424B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hypermarcas (HYPMY) Brazil $5.703B 20.50
Arrowhead Pharmaceuticals (ARWR) United States $5.449B 82.51
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Nektar Therapeutics (NKTR) United States $4.132B 0.00
United Therapeutics (UTHR) United States $4.056B 0.00
Sage Therapeutics (SAGE) United States $3.882B 0.00
Evotec AG (EVTCY) Germany $3.809B 62.32
FibroGen (FGEN) United States $3.706B 108.92
Taro Pharmaceutical Industries (TARO) Israel $3.305B 12.17
PTC Therapeutics (PTCT) United States $3.174B 0.00
ArQule (ARQL) United States $2.417B 0.00
Zogenix (ZGNX) United States $2.415B 0.00
ChemoCentryx (CCXI) United States $2.186B 0.00
Tilray (TLRY) Canada $2.147B 0.00
Xencor (XNCR) United States $2.126B 64.62
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.104B 0.00
Heron Therapeutics (HRTX) United States $2.020B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.003B 63.85
Pacira Pharmaceuticals (PCRX) United States $1.774B 52.47
USANA Health Sciences (USNA) United States $1.734B 18.50
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.534B 10.47
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.447B 17.58
Theravance Biopharma (TBPH) Cayman Islands $1.438B 0.00
Endo (ENDP) Ireland $1.331B 2.45
Enanta Pharmaceuticals (ENTA) United States $1.163B 26.56
Portola Pharmaceuticals (PTLA) United States $1.160B 0.00
Karyopharm Therapeutics (KPTI) United States $1.155B 0.00
Aerie Pharmaceuticals (AERI) United States $1.136B 0.00
Dermira (DERM) United States $1.044B 0.00
Radius Health (RDUS) United States $0.970B 0.00
Akebia Therapeutics (AKBA) United States $0.890B 0.00
Collegium Pharmaceutical (COLL) United States $0.808B 0.00
ImmunoGen (IMGN) United States $0.741B 0.00
Flexion Therapeutics (FLXN) United States $0.696B 0.00
TherapeuticsMD (TXMD) United States $0.692B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.615B 0.00
Translate Bio (TBIO) United States $0.513B 0.00
Molecular Templates (MTEM) United States $0.509B 0.00
Organogenesis Holdings (ORGO) United States $0.493B 0.00
DURECT (DRRX) United States $0.489B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.456B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.452B 54.88
Corbus Pharmaceuticals Holdings (CRBP) United States $0.449B 0.00
Siga Technologies (SIGA) United States $0.423B 9.67
BioCryst Pharmaceuticals (BCRX) United States $0.423B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.419B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.410B 17.68
Innate Pharma SA (IPHYF) France $0.403B 0.00
OptiNose (OPTN) United States $0.383B 0.00
Lannett Co Inc (LCI) United States $0.379B 4.41
Spectrum Pharmaceuticals (SPPI) United States $0.374B 0.00
Recro Pharma (REPH) United States $0.370B 0.00
Harpoon Therapeutics (HARP) United States $0.364B 0.00
Calithera Biosciences (CALA) United States $0.351B 0.00
Indivior (INVVY) United States $0.347B 1.25
Rafael Holdings (RFL) United States $0.320B 0.00
KalVista Pharmaceuticals (KALV) United States $0.303B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.290B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.265B 0.00
Jounce Therapeutics (JNCE) United States $0.256B 3.42
MEI Pharma (MEIP) United States $0.242B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.228B 0.00
Concordia (CXRXF) Canada $0.225B 0.00
Ocular Therapeutix (OCUL) United States $0.218B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.214B 0.00
IMV INC (IMV) Canada $0.201B 0.00
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Xeris Pharmaceuticals (XERS) United States $0.167B 0.00
CannTrust Holdings (CTST) Canada $0.166B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.158B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.140B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.130B 0.00
CV Sciences (CVSI) United States $0.113B 0.00
Aquestive Therapeutics (AQST) United States $0.109B 0.00
Otonomy (OTIC) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Champions Oncology (CSBR) United States $0.100B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.092B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.085B 0.00
PolarityTE (PTE) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
CTI BioPharma (CTIC) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.27
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
AgeX Therapeutics (AGE) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.064B 15.86
Entasis Therapeutics Holdings (ETTX) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Iterum Therapeutics (ITRM) Ireland $0.061B 0.00
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
Onconova Therapeutics (ONTX) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
IsoRay (ISR) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.048B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Biomerica (BMRA) United States $0.028B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
VAXART, INC (VXRT) United States $0.019B 0.00
Cardiome Pharma (CORV) Canada $0.019B 0.00
Shineco (TYHT) China $0.018B 0.00
NOVAN INC (NOVN) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Vical (BBI) United States $0.012B 0.00
Lipocine (LPCN) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Hemispherx BioPharma (AIM) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00